XYXiaofei Yu

Xiaofei Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaofei Yu has a total of 231 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Career pathways, part 19

    by Xiaofei Yu, Michael Lukey

  • Open Access

    Alterations in short-chain fatty acid-associated gut microbiota and tight junction integrity in adolescent major depressive disorder

    by Xueer Liu, Aoyi Geng, Mengyu Xia, Jiabin Lan, Hongyan Wu, Zichu Zhou, Fang Huang, Yuqian He, Tingting Lei, Junguk Hur, et al.

    Major depressive disorder (MDD) often begins during adolescence, a critical developmental period during which nearly 50% of lifetime cases emerge. Despite its high prevalence and impact, objective diagnostic biomarkers for adolescent MDD remain limited, particularly those related to gut microbiota. Our study examined potential co-diagnostic biomarkers from peripheral blood and fecal samples in adolescents with MDD. We enrolled drug-naïve adolescents with first-episode MDD (n = 46, aged ≤18 years, 71.74% female) and age-/sex-matched healthy controls (HCs, n = 44). The levels of tight junction proteins (Claudin-5, Zonulin, FABP) and inflammatory biomarkers (IL-6, IL-8, TNF-α, and CRP) were markedly elevated in the plasma of adolescents with MDD, indicating gut barrier dysfunction and systemic inflammation. The microbiome in MDD patients exhibited a lower Firmicutes-to-Bacteroidetes ratio. At the genus level, Intestinimonas and Barnesiella were significantly enriched, while Dialister and Collinsella were considerably reduced. Integrating Collinsella abundance with tight junction proteins and inflammatory markers significantly improved diagnostic performance, achieving an area under the curve (AUC) of 0.964. Moreover, Collinsella negatively correlated with sex, Claudin-5, and TNF-α. Claudin-5 was strongly associated with short-chain fatty acids (SCFAs)-related pathways, including alanine, aspartate, glutamate metabolism, D-glutamine and D-glutamate metabolism, and autophagy regulation. Treatment of Caco-2 cells with propionate and butyrate confirmed the regulatory effects of SCFAs on tight junction biomarkers. These findings suggest the interplay between gut dysbiosis, barrier dysfunction, and inflammation in adolescent MDD and support microbiota-host biomarkers as a promising strategy for improving MDD diagnostic precision.


  • Open Access

    Mediator Subunit MED16 Collaborates with UBP1-TFCP2 to Control Transcriptional Activation or Repression via Promoter Positional Specificity

    by Yuanming Zheng, Xiaying Zhao, Ming Yang, Xinyi Yang, Huanzhang Zhu, Xiaofei Yu, Qiang Zhou, Gang Wang

    The Mediator complex is an evolutionarily conserved transcriptional coactivator with well-characterized structure and function, though the roles of its dissociable subunits remain incompletely defined. Here, we demonstrate that Mediator subunit MED16 dissociates from the core complex to form a subcomplex with transcription factors UBP1 and TFCP2, and this interaction modulates transcriptional activation or repression in a context-dependent manner. Using protein purification coupled with mass spectrometry, we identified MED16 as a binding partner of UBP1-TFCP2. Gene expression analyses showed that UBP1 interacts with MED16 to activate a subset of silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation. Conversely, the MED16-UBP1 interaction suppresses HIV-1 transcription, thereby reinforcing viral latency. Mechanistically, MED16 and UBP1 cooperatively bind the HIV-1 transcriptional start site (TSS) to inhibit preinitiation complex assembly. Genomic-scale analyses further demonstrated that transcription is activated when the UBP1-TFCP2 binding motif is proximal to the TSS, but repressed when the motif overlaps the TSS. Collectively, our findings identify a novel MED16-UBP1 interaction, define its dual role in transcriptional regulation, and highlight the therapeutic potential of targeting this axis in HIV-1 infection.


  • Open Access

    Mediator Subunit MED16 Collaborates with UBP1-TFCP2 to Control Transcriptional Activation or Repression via Promoter Positional Specificity

    by Yuanming Zheng, Xiaying Zhao, Ming Yang, Xinyi Yang, Huanzhang Zhu, Xiaofei Yu, Qiang Zhou, Gang Wang

    The Mediator complex is an evolutionarily conserved transcriptional coactivator with well-characterized structure and function, though the roles of its dissociable subunits remain incompletely defined. Here, we demonstrate that Mediator subunit MED16 dissociates from the core complex to form a subcomplex with transcription factors UBP1 and TFCP2, and this interaction modulates transcriptional activation or repression in a context-dependent manner. Using protein purification coupled with mass spectrometry, we identified MED16 as a binding partner of UBP1-TFCP2. Gene expression analyses showed that UBP1 interacts with MED16 to activate a subset of silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation. Conversely, the MED16-UBP1 interaction suppresses HIV-1 transcription, thereby reinforcing viral latency. Mechanistically, MED16 and UBP1 cooperatively bind the HIV-1 transcriptional start site (TSS) to inhibit preinitiation complex assembly. Genomic-scale analyses further demonstrated that transcription is activated when the UBP1-TFCP2 binding motif is proximal to the TSS, but repressed when the motif overlaps the TSS. Collectively, our findings identify a novel MED16-UBP1 interaction, define its dual role in transcriptional regulation, and highlight the therapeutic potential of targeting this axis in HIV-1 infection.

  • Open Access

    Intravital imaging of translocated bacteria via fluorogenic labeling of gut microbiota in situ

    by Xinqi Fan, Yingjun Zhou, Wenjuan Bai, Xue Li, Liyuan Lin, Huibin Lin, Ming Yang, Xiaofei Yu, Jing Wang, Liang Lin, et al.

    The translocation of bacteria from intestinal tracts into blood vessels and distal organs plays pivotal roles in the pathogenesis of numerous severe diseases. Intravital monitoring of bacterial translocation, however, is not yet feasible, which greatly hinders us from comprehending this spatially and temporally dynamic process. Here we report an in vivo fluorogenic labeling method, which enables in situ imaging of mouse gut microbiota and real-time tracking of the translocated bacteria. By mimicking the peptidoglycan stem peptide in bacteria, a tetrapeptide probe composed of alternating D- and L-amino acids and separately equipped with a fluorophore and a quencher on the N- and C-terminal amino acid, is designed. Because of its resistance to host proteases, it can be directly used in gavage and achieves fluorogenic labeling of the microbiota in the gut via the functioning of the L,D-transpeptidases of the labeled bacteria. Using intravital two-photon microscopy, we then successfully visualize the translocation of gut bacteria into the bloodstream and liver in obesity mouse models. This technique can help further exploration into the spatiotemporal activities of gut microbiota in vivo, and be valuable in investigating the less understood pathogenicity of bacterial translocation in many severe diseases.


  • Open Access

    Elevated IL-22 as a result of stress-induced gut leakage suppresses septal neuron activation to ameliorate anxiety-like behavior

    by Mengyu Xia, Junmei Lu, Jiabin Lan, Teng Teng, Rani Shiao, Hongbin Sun, Zheyu Jin, Xueer Liu, Jie Wang, Hongyan Wu, et al.


  • Open Access

    MCRS1 sensitizes T cell–dependent immunotherapy by augmenting MHC-I expression in solid tumors

    by Xue Li, Han Yi, Zheyu Jin, Kaitao Jiang, Kangkang Xue, Jin Wang, Yuping Qian, Qian Xiang, Sijing Zhu, Runhe Yan, et al.

    Dampened antigen presentation underscores the resistance of pancreatic cancer to T cell–mediated anti-tumor immunity, rendering immunotherapy largely ineffective. By high-throughput CRISPR activation perturbation, we discovered that the transcriptional regulator MCRS1 significantly augmented the sensitivity of mouse pancreatic cancer cells to T cell immunity in vitro and in vivo. Mechanistically, MCRS1 interacted with the transcription factor and genome organizer YY1 to coordinately increase the chromatin accessibility and expression of MHC-I genes. Elevated MCRS1 subverted MHC-I suppression and activated anti-tumor T cells, which sensitized mouse pancreatic cancer to α-PD-1 therapy. Remarkably, high MCRS1 expression was associated with increased T cell infiltration and extended survival of patients with pancreatic cancer and was predictive of favorable responses to α-PD-1 therapy in patients with lung cancer. Together, our study uncovers that MCRS1 sensitizes cancer cells to T cell immunity by transcriptionally subverting MHC-I suppression, which enhances the effectiveness of α-PD-1 therapy in mice and humans, paving the way to further improve immunotherapy against solid tumors.


  • Open Access

    Bidirectional regulation of motor circuits using magnetogenetic gene therapy

    by Santiago R. Unda, Lisa E. Pomeranz, Roberta Marongiu, Xiaofei Yu, Leah Kelly, Gholamreza Hassanzadeh, Henrik Molina, George Vaisey, Putianqi Wang, Jonathan P. Dyke, et al.

    Here, we report a magnetogenetic system, based on a single anti-ferritin nanobody-TRPV1 receptor fusion protein, which regulated neuronal activity when exposed to magnetic fields. Adeno-associated virus (AAV)–mediated delivery of a floxed nanobody-TRPV1 into the striatum of adenosine-2a receptor–Cre drivers resulted in motor freezing when placed in a magnetic resonance imaging machine or adjacent to a transcranial magnetic stimulation device. Functional imaging and fiber photometry confirmed activation in response to magnetic fields. Expression of the same construct in the striatum of wild-type mice along with a second injection of an AAVretro expressing Cre into the globus pallidus led to similar circuit specificity and motor responses. Last, a mutation was generated to gate chloride and inhibit neuronal activity. Expression of this variant in the subthalamic nucleus in PitX2-Cre parkinsonian mice resulted in reduced c-fos expression and motor rotational behavior. These data demonstrate that magnetogenetic constructs can bidirectionally regulate activity of specific neuronal circuits noninvasively in vivo using clinically available devices.


  • Top Cited Papers

    Hydrogen sulfide produced by the gut microbiota impairs host metabolism via reducing GLP-1 levels in male mice

    by Qingqing Qi, Huijie Zhang, Zheyu Jin, Changchun Wang, Mengyu Xia, Bandy Chen, Bomin Lv, Ludmila Peres Diaz, Xue Li, Ru Feng, et al.

    Dysbiosis of the gut microbiota has been implicated in the pathogenesis of metabolic syndrome (MetS) and may impair host metabolism through harmful metabolites. Here, we show that Desulfovibrio, an intestinal symbiont enriched in patients with MetS, suppresses the production of the gut hormone glucagon-like peptide 1 (GLP-1) through the production of hydrogen sulfide (H2S) in male mice. Desulfovibrio-derived H2S is found to inhibit mitochondrial respiration and induce the unfolded protein response in intestinal L cells, thereby hindering GLP-1 secretion and gene expression. Remarkably, blocking Desulfovibrio and H2S with an over-the-counter drug, bismuth subsalicylate, improves GLP-1 production and ameliorates diet-induced metabolic disorder in male mice. Together, our study uncovers that Desulfovibrio-derived H2S compromises GLP-1 production, shedding light on the gut-relayed mechanisms by which harmful microbiota-derived metabolites impair host metabolism in MetS and suggesting new possibilities for treating MetS.


  • GOSpel for tiny allies

    by Wei Hu, Xiaofei Yu